Physician

Sangjin Oh, M.D.

According to 2025 Medicare claims, Sangjin Oh, M.D. (NPI: 1316966179) practices neurology in the Baltimore-Columbia-Towson, MD market, with the plurality of this provider's patient population coming from Anne Arundel, MD. This provider's primary affiliated billing organization is SANGJIN OH MD PA (NPI: 1730745159; TIN: 834632220) and primary practice location at 21061-7000.

Oh's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,076 traditional Medicare patients, billed 82,324 HCPCS/CPT codes, and received $2,834,425 in Medicare payments. The top billing code was 99205 (New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more). Part D data shows 6,154 prescription claims across 837 beneficiaries totaling $7,754,297 in drug costs, led by Kesimpta Pen (Ofatumumab). DME data shows 2,731 claims. Open Payments data shows 626 records totaling $210,275. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $163,855 to $2,834,425. Similarly, Part D prescription costs have risen steadily, from $3,133,670 to $7,754,297. In contrast, DME billing represents a smaller volume and did not follow a clear longitudinal pattern.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	743	1,700	$163,855
2016	886	1,892	$181,008
2017	811	1,688	$141,458
2018	829	1,753	$165,748
2019	937	1,873	$188,847
2020	818	26,934	$1,039,332
2021	905	38,882	$1,750,898
2022	942	42,678	$1,982,527
2023	1,071	54,121	$2,549,612
2024	1,076	82,324	$2,834,425

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	294	3,631	$3,133,670
2016	459	4,346	$3,667,488
2017	481	4,729	$4,920,952
2018	507	4,734	$4,459,820
2019	534	5,017	$4,036,191
2020	550	4,980	$4,984,728
2021	540	4,704	$5,706,773
2022	639	4,696	$5,507,568
2023	682	5,194	$7,517,272
2024	837	6,154	$7,754,297

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	1,172	2,214	$80,232
2016	1,241	2,485	$77,159
2017	1,112	2,079	$60,423
2018	1,219	2,181	$66,239
2019	2,250	4,113	$137,267
2020	2,275	4,807	$162,245
2021	1,785	3,665	$127,751
2022	1,494	3,118	$191,013
2023	1,340	2,881	$184,800
2024	1,256	2,731	$188,031

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99205	New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more	208	208	$155
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	785	1,208	$83
99203	New patient office or other outpatient visit with low level of medical decision making, if using time, 30 minutes or more	106	107	$78
95886	Needle measurement of electrical activity in arm or leg muscles, complete study	129	135	$71
99442	Telephone medical discussion with physician, 11-20 minutes	67	81	$66

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Kesimpta Pen	Ofatumumab	277	8,744	$2,754,957
Gammagard Liquid	Immun Glob G(Igg)/Gly/Iga Ov50	15	364	$345,172
Ingrezza	Valbenazine Tosylate	23	930	$273,326
Gamunex-C	Immune Globul G/Gly/Iga Avg 46	15	426	$268,393
Bafiertam	Monomethyl Fumarate	15	1,179	$247,626

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
J7340	Carbidopa 5 mg/levodopa 20 mg enteral suspension, 100 ml	N	N/R	13	$65,943
A7030	Full face mask used with positive airway pressure device, each	N	94	210	$18,266
A7031	Face mask interface, replacement for full face mask, each	N	91	216	$17,770
A7032	Cushion for use on nasal mask interface, replacement only, each	N	69	146	$13,368
A4222	Infusion supplies for external drug infusion pump, per cassette or bag (list drugs separately)	N	N/R	13	$13,293

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	622	$187,545	EMD Serono, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	4	$22,730	TG Therapeutics, Inc.
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Sangjin Oh, M.D.?

Tedicare shows public-source Medicare data for Sangjin Oh, M.D. (NPI 1316966179), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Sangjin Oh, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Sangjin Oh, M.D.?

Sangjin Oh, M.D. is linked to SANGJIN OH MD PA (billing NPI 1730745159) in the available physician profile data.

Does Sangjin Oh, M.D. have Open Payments data?

Sangjin Oh, M.D. has 626 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.